Healthcare -
Biotechnology - NASDAQ - US
$ 0.5008
-4.32 %
$ 61.9 M
Market Cap
-0.83
P/E
MRSN - STOCK-BASED COMPENSATION
Stock-based Compensation MRSN - Mersana Therapeutics, Inc.
21.1 M
LAST VALUE
7.15%
2 YEAR CAGR
40.33%
5 YEAR CAGR
0.00%
10 YEAR CAGR